You are now leaving the ViiV Exchange Belgium-Luxembourg site.
For full access to ViiV Exchange content, you’ll need to
Please contact our Medical Information representative
+32 10 85 65 00
Thank you for choosing to report a suspected adverse event
For Belgium: Please report adverse events to the Belgian Centre for Pharmacovigilance for medicines for Human use (BCPH) of the Federal Agency for Medicines and Health Products (FAMHP) on the following address: firstname.lastname@example.org or via the ‘yellow card’ available on the website http://www.fagg-afmps.be or to ViiV Healthcare SPRL/BVBA at the number +32 10 85 65 00.
For Luxembourg: Please report adverse events to the Minister of Health of Grand-Duché of Luxembourg (Pharmacy and Drug Division, at fax number +35 2 24795615 or by post) or at Regional Pharmacovigilance Centre of Lorraine (at fax number +33 3 83 32 33 44 or at email@example.com) or to ViiV Healthcare SPRL/BVBA at the number +32 10 85 65 00.
©2019 ViiV Healthcare group of companies.
All rights reserved.
E.R./V.U.: ViiV Healthcare
Company No. 0818.038.513
Site Apollo Avenue Pascal 2-4-6 / 1300 Wavre BELGIUM
PM-BE-HVX-WCNT-190006 - November 2019